173期刊网
     JOURNAL OF PERSONALITY DISORDERS
    期刊介绍
		该 杂志人格障碍 一直是奇异论坛专门向临床显著人格障碍的诊断和治疗。该杂志促进了研究人员和从业者之间以各种方向和方法开展对话。其国际影响力已经建立,用户遍布30多个国家。这本多学科期刊的定期出版物包括: *正常人和病理性人格与发展研究 *评估人格的新方法 *人格障碍的病因和临床分类 *流行病学研究和诊断标准的结局研究 *治疗技术和创新 该期刊的影响因子为0
		
The Journal of Personality Disorders has long been a singular forum devoted exclusively to the diagnosis and treatment of clinically significant personality disorders. The journal fosters dialogue among researchers and practitioners working from a variety of orientations and approaches. Its international impact is well established, with subscribers in over 30 countries. This multidisciplinary journal regularly features: * Research on normal and pathological personality and development * New methodologies for assessing personality * Etiologies and clinical classifications for personality disorders * Epidemiological studies and outcomes research on diagnostic criteria * Treatment techniques and innovations The impact factor of this journal is 0
The Journal of Personality Disorders has long been a singular forum devoted exclusively to the diagnosis and treatment of clinically significant personality disorders. The journal fosters dialogue among researchers and practitioners working from a variety of orientations and approaches. Its international impact is well established, with subscribers in over 30 countries. This multidisciplinary journal regularly features: * Research on normal and pathological personality and development * New methodologies for assessing personality * Etiologies and clinical classifications for personality disorders * Epidemiological studies and outcomes research on diagnostic criteria * Treatment techniques and innovations The impact factor of this journal is 0
| 全名/缩写 | /JOURNAL OF PERSONALITY DISORDERS | 
| 期刊ISSN | 0885-579X | 
| 2022-2023影响因子 | 0 实时影响因子查询 (由greensci.net提供-2019 New!) | 
| 最新自引率 | 0.00 | 
| 期刊官方网站 | |
| 是否OA开放访问 | |
| 出版国家或地区 | |
| 出版年份 | 0 | 
| 中科院JCR分区 | 大类:小类: | 
| SCI期刊coverage | Science Citation Index Expanded(科学引文索引扩展) | 
| 审稿速度(网友添加,非官方) | 
	   ×
	   
	
		绿色通道审稿   加急发表
		可添加微信号:meibisi123